Pregnancy, Babies, Parenting News & Tips

Vanderbilt Scientists Discover Potential New Way to Treat Anxiety

By Staff Reporter / Aug 04, 2013 07:03 PM EDT
  • Lawrence Marnett, Ph.D., and Sachin Patel, M.D., Ph.D., Vanderbilt University Medical Center
  • (Photo : Vanderbilt University/Stephen Doster) Lawrence Marnett, Ph.D., (left) and Sachin Patel, M.D., Ph.D., have discovered that chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural "endocannabinoids" without gastrointestinal side effects.

Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural "endocannabinoids" without gastrointestinal side effects, Vanderbilt University scientists will report next week.

Endocannabinoids are natural signaling molecules that activate cannabinoid receptors in the brain, the same receptors turned on by the active ingredient in marijuana.

Like Us on Facebook

These receptors are also found in the gastrointestinal system and elsewhere in the body, and there is evidence that they play a role in wide range of physiological and pathological processes, in addition to modulating stress and anxiety.

If the "substrate-selective" COX-2 inhibitors developed at Vanderbilt also work in humans without side effects, they could represent a new approach to treating mood and anxiety disorders, the researchers conclude in a paper to be posted online Sunday in the journal Nature Neuroscience.

Clinical trials of some of these potential drugs could begin in the next several years, said Lawrence Marnett, Ph.D., director of the Vanderbilt Institute of Chemical Biology and the paper's co-senior author with Sachin Patel, M.D., Ph.D.

The Vanderbilt scientists are pursuing other potential applications of activating endocannabinoids by substrate-selective COX-2 inhibition, including relieving pain, treating movement disorders, and possibly preventing colon cancer.

"The door is really wide open," said Patel, assistant professor of Psychiatry and of Molecular Physiology & Biophysics. "We've just scratched the surface."

Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) relieve pain and inflammation by blocking either or both of the cyclooxygenase (COX) enzymes, which produce pro-inflammatory prostaglandins.

It has been known for several years that COX-2 inhibition also activates endocannabinoids.

Because the "substrate selective" inhibitors developed at Vanderbilt increase endocannabinoid levels in the mouse without blocking prostaglandin production, "we think (they) will not have the gastrointestinal and possibly cardiovascular side effects that other NSAIDs do," said Marnett, University Professor and Mary Geddes Stahlman Professor of Cancer Research.

"We thought we knew everything there was to know about (COX-2 inhibitors) until about five years ago when we discovered the substrate selective inhibition," he added. The approach used by the Vanderbilt team "is a really powerful way to help design the next generation of drugs."

Provided by Vanderbilt University Medical Center
Featured Video : Never Leave Your Child Alone in the Car: Parents Urged to Take Heat Stroke Seriously Before it's too late

Antibiotics in infancy may be linked to childhood obesity: study

Kids who receive several rounds of antibiotics before age two may be at an increased risk of being overweight by age five, suggests a new study.

Read More »

U.S. military to quickly ramp up Ebola mission in Liberia

A Doctors Without Borders health worker takes off his protective gear under the surveillance of a colleague at a treatment facility for Ebola victims in Monrovia September 29, 2014.

Read More »

World must do more to battle Ebola in West Africa: Obama

1 of 2. Health workers surround an Ebola patient who escaped from quarantine from Monrovia's Elwa hospital, in the centre of Paynesville in this still image taken from a September 1, 2014 video.

Read More »

Health benefits of parkrun stretch well beyond the physical

Participants take part in a parkrun event at Bushy Park in London August 2, 2014.

Read More »

Money talks: Obamacare initiative makes headway in Republican states

A man looks over the Affordable Care Act (commonly known as Obamacare) signup page on the HealthCare.gov website in New York in this October 2, 2013 photo illustration.

Read More »

Doctor calls for blood donations to treat Liberian Ebola victims

1 of 2. Health workers surround an Ebola patient who escaped from quarantine from Monrovia's Elwa hospital, in the centre of Paynesville in this still image taken from a September 1, 2014 video.

Read More »

U.S. hospitals unprepared to handle Ebola waste

1 of 3. An isolation room at Emory University Hospital in Atlanta is shown in this undated file handout photo courtesy of Emory Hospital.

Read More »

Sierra Leone wraps up three-day Ebola lockdown

An empty street is seen at the start of a three-day national lockdown in Freetown September 19, 2014.

Read More »

Cerner and Athenahealth say integrating with Apple's mobile health service

The Apple logo is pictured at a retail store in the Marina neighborhood in San Francisco, California April 23, 2014.

Read More »

White House calls for task force to tackle antibiotic-resistant bugs

A medical technician prepares samples in the specimen set-up area of the Vanderbilt Clinical Microbiology Lab in Nashville, Tennessee on October 19, 2012.

Read More »

U.N. to deploy Ebola mission as death toll reaches 2,630

1 of 3. Health workers remove the body of Prince Nyentee, a 29-year-old man whom local residents said died of Ebola virus in Monrovia September 11, 2014.

Read More »

IMF says Ebola hits economic growth in West Africa

A fan of Ivory coast holds a sign with a message against Ebola during the 2015 African Nations Cup qualifying soccer match between Ivory Coast and Sierra Leone at the Felix Houphouet Boigny stadium in Abidjan September 6, 2014.

Read More »

Real Time Analytics